Valeant Pharmaceuticals International (NYSE:VRX) : Wednesdays money flow analysis of Valeant Pharmaceuticals International (NYSE:VRX) indicates the selling of stock on the strength of price. The investors sold the stock on every rise as seen in the downtick transactions of $78.87 million. In comparison, the inflow of money on upticks was a meager $70.96 million. The dollar value of composite uptick trades minus the downtick trades was negative $7.91 million. The uptick to downtick ratio of 0.9 in the money flow shows weakness. The uptick block trades were valued at $5.19 million. The downtick transaction value was high at $9.94 million, which denotes distribution on strength. The uptick to downtick ratio of block trades was 0.52. Hence, the net money flow in the stock was negative ($4.75 million). Valeant Pharmaceuticals International (NYSE:VRX) gained $0.25 at $20.25, a change of 1.25% over the previous days close.
In an insider trading activity, The Securities and Exchange Commission has divulged in a Form 4 filing that the CEO of Valeant Pharmaceuticals International, Inc., Papa Joseph C had purchased shares worth of $4,944,960 in a transaction dated on June 10, 2016. A total of 202,000 shares were purchased at a price of $24.48 per share. The information is based on open market trades at the market prices.Option exercises are not covered. Currently the company Insiders own 8.62% of Valeant Pharmaceuticals International shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 9.02% . Institutional Investors own 78.38% of Valeant Pharmaceuticals International shares. During last six month period, the net percent change held by insiders has seen a change of 9.02%.
The company shares have dropped -91.24% from its 1 Year high price. On Aug 6, 2015, the shares registered one year high at $263.81 and the one year low was seen on Jun 27, 2016. The 50-Day Moving Average price is $25.26 and the 200 Day Moving Average price is recorded at $56.49. Valeant Pharmaceuticals International (NYSE:VRX): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $20.30 and $19.64 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $20.50. The buying momentum continued till the end and the stock did not give up its gains. It closed at $20.27, notching a gain of 1.35% for the day. The total traded volume was 17,599,930 . The stock had closed at $20.00 on the previous day.
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices), which are marketed directly or indirectly in over 100 countries. The Company operates through two segments: developed markets and emerging markets. The Companys developed markets segment consists of sales in the United States of pharmaceutical products, OTC products, and medical device products. The Companys Emerging Markets segment consists of branded generic pharmaceutical products and branded pharmaceuticals, OTC products, and medical device products.